These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8896488)
1. T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2. Carmack MA; Yasukawa LL; Chang SY; Tran C; Saldana F; Arvin AM; Prober CG J Infect Dis; 1996 Nov; 174(5):899-906. PubMed ID: 8896488 [TBL] [Abstract][Full Text] [Related]
13. Augmentation of B7 expression by herpes simplex virus antigen. Singh R; Kumar A; Diaz-Mitoma F Hum Immunol; 2003 Aug; 64(8):780-6. PubMed ID: 12878356 [TBL] [Abstract][Full Text] [Related]
14. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes. Osorio Y; Ghiasi H J Virol; 2003 May; 77(10):5774-83. PubMed ID: 12719570 [TBL] [Abstract][Full Text] [Related]
15. CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins. Koelle DM; Schomogyi M; McClurkan C; Reymond SN; Chen HB J Virol; 2000 Dec; 74(23):11422-5. PubMed ID: 11070045 [TBL] [Abstract][Full Text] [Related]
16. Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection. Singh R; Kumar A; Creery WD; Ruben M; Giulivi A; Diaz-Mitoma F Clin Exp Immunol; 2003 Jul; 133(1):97-107. PubMed ID: 12823283 [TBL] [Abstract][Full Text] [Related]
17. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity. BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561 [TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 1 (HSV-1) specific T-cell generation from HLA-A1- and HLA-A2-positive donors for adoptive immunotherapy. Ma CK; Clancy L; Deo S; Blyth E; Micklethwaite KP; Gottlieb DJ Cytotherapy; 2017 Jan; 19(1):107-118. PubMed ID: 27793552 [TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes. Kim M; Osborne NR; Zeng W; Donaghy H; McKinnon K; Jackson DC; Cunningham AL J Immunol; 2012 May; 188(9):4158-70. PubMed ID: 22467654 [TBL] [Abstract][Full Text] [Related]
20. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific. Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]